Xeris Pharmaceuticals | الأصول



Assets تغيير تاريخ
Adcock Ingram Holdings ZAR 8.74B 388.13M 2024-12
Celltrion KRW 20.96T 96.41B 2025-03
Cspc Pharmaceutical CNY 44.39B 3.51B 2024-12
Dianthus Therapeutics USD 326.08M 47.93M 2025-06
Divis Laboratories Ltd 169.32B 13.46B 2025-03
Eli Lilly USD 100.92B 11.53B 2025-06
Kangmei Pharma CNY 13.64B 69.1M 2025-06
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 869.6M 37.58M 2025-06
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 65.33M 6.17M 2024-12
Neuren Pharmaceuticals AUD 409.71M 181.55M 2024-12
Organigram Holdings CAD 564.62M 85.41M 2025-06
Pacira USD 1.54B 49.41M 2025-06
Perrigo USD 10.09B 334.3M 2025-06
Pharma Mar EUR 348.25M 14.75M 2025-06
Qiagen NV USD 5.82B 278.39M 2025-06
Sartorius EUR 10.03B 85.1M 2025-06
Sino Biopharmaceutical CNY 65.41B 1.3B 2024-12
Supernus Pharmaceuticals USD 1.38B 35.11M 2025-06
Tilray USD 4.19B 70.11M 2024-11
Zz Pientze Pharmaceu 18.71B 224.21M 2025-06


Xeris Pharmaceuticals الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Sep 2025.